Eledon Pharmaceuticals Inc (ELDN)

Jan 29, 2025

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference - The Manila Times

Jan 29, 2025

Jan 29, 2025

Eledon CEO to Reveal Latest Biotech Developments at Major Guggenheim Conference - StockTitan

Jan 29, 2025

Jan 28, 2025

Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business - Seeking Alpha

Jan 28, 2025

Jan 28, 2025

Guggenheim Initiates Eledon Pharmaceuticals at Buy With $9 Price Target -January 28, 2025 at 07:34 am EST - Marketscreener.com

Jan 28, 2025

Jan 28, 2025

Eledon Pharmaceuticals (NASDAQ:ELDN) Coverage Initiated by Analysts at Guggenheim - MarketBeat

Jan 28, 2025

Jan 25, 2025

Inspire Investing LLC Invests $802,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Jan 25, 2025

Jan 24, 2025

Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal

Jan 24, 2025

Jan 23, 2025

Cantor Fitzgerald Comments on ELDN FY2025 Earnings - Defense World

Jan 23, 2025

Jan 22, 2025

Kidney Transplant Rejection Market Expected to Experience - openPR

Jan 22, 2025

Jan 22, 2025

Cantor Fitzgerald Weighs in on ELDN FY2025 Earnings - MarketBeat

Jan 22, 2025

Jan 20, 2025

Analyst Forecast For Eledon Pharmaceuticals Inc (NASDAQ: ELDN) - Stocks Register

Jan 20, 2025

Jan 14, 2025

Eledon Pharmaceuticals highlights recent business milestones, 2025 outlook - MSN

Jan 14, 2025

Jan 13, 2025

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook - GlobeNewswire

Jan 13, 2025

Jan 13, 2025

Eledon's Tegoprubart Achieves Major Breakthrough in Kidney Transplant Trials, Secures $135M Funding - StockTitan

Jan 13, 2025

Jan 11, 2025

Geode Capital Management LLC Buys 33,569 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World

Jan 11, 2025

Jan 07, 2025

Eledon Pharmaceuticals (NASDAQ:ELDN) Trading Down 3.9%Should You Sell? - MarketBeat

Jan 07, 2025

Dec 20, 2024

Eledon Pharmaceuticals adjusts CEO bonus structure - Investing.com

Dec 20, 2024

Dec 16, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Update - MarketBeat

Dec 16, 2024

Nov 24, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 24, 2024

Nov 23, 2024

HC Wainwright Has Negative Outlook for ELDN Q4 Earnings - Defense World

Nov 23, 2024

Nov 22, 2024

HC Wainwright Issues Pessimistic Forecast for ELDN Earnings - MarketBeat

Nov 22, 2024

Nov 21, 2024

Eledon Pharmaceuticals retains shares target, Buy rating on clinical trial progress - Investing.com Australia

Nov 21, 2024

Nov 20, 2024

Eledon Pharmaceuticals retains shares target, Buy rating on clinical trial progress By Investing.com - Investing.com South Africa

Nov 20, 2024

Nov 20, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Given Buy Rating at HC Wainwright - MarketBeat

Nov 20, 2024

Nov 18, 2024

FY2024 EPS Estimates for ELDN Boosted by Cantor Fitzgerald - MarketBeat

Nov 18, 2024

Nov 15, 2024

Lifesci Capital Issues Optimistic Outlook for ELDN Earnings - MarketBeat

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Shares in Eledon Pharmaceuticals Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Institutions along with individual investors who hold considerable shares inEledon Pharmaceuticals, Inc. (NASDAQ:ELDN) come under pressure; lose 16% of holdings value - Simply Wall St

Nov 14, 2024

Nov 14, 2024

Hopkins alum leads Eledon Pharmaceuticals in breakthrough diabetes tegoprubart treatment - Johns Hopkins News-Letter

Nov 14, 2024

Nov 13, 2024

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results - The Manila Times

Nov 13, 2024

Nov 12, 2024

Eledon Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks

Nov 12, 2024

Nov 12, 2024

Eledon Pharma Surges: $85M Offering, Strong Trial Results Drive Q3 Success | ELDN Stock | ELDN Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Amyotrophic Lateral Sclerosis Treatment Market to Grow by USD 663.7 Million from 2024-2028, as Rising Incidence Drives Demand with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve

Nov 08, 2024

Nov 06, 2024

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference - The Manila Times

Nov 06, 2024

Nov 06, 2024

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation - The Bakersfield Californian

Nov 06, 2024

Nov 06, 2024

Eledon Pharmaceuticals CEO to Present at Guggenheim's First Healthcare Innovation Conference | ELDN Stock News - StockTitan

Nov 06, 2024

Nov 05, 2024

RA Capital Management, L.P. Acquires New Stake in Eledon Pharmac - GuruFocus.com

Nov 05, 2024

Nov 01, 2024

Biotechnology Value Fund L P's Strategic Acquisition in Eledon P - GuruFocus.com

Nov 01, 2024

Oct 31, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains - Investing.com Australia

Oct 31, 2024

Oct 30, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains By Investing.com - Investing.com South Africa

Oct 30, 2024

Oct 30, 2024

SEC Form 424B5 filed by Eledon Pharmaceuticals Inc. - Quantisnow

Oct 30, 2024